Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Controls in Experiments01:13

Controls in Experiments

When conducting an experiment, it is crucial to have control to reduce bias and accurately measure the dependent variables. It also marks the results more reliable. Controls are elements in an experiment that have the same characteristics as the treatment groups but are not affected by the independent variable. By sorting these data into control and experimental conditions, the relationship between the dependent and independent variables can be drawn. A randomized experiment always includes a...
Strategies for Assessing and Addressing Confounding01:25

Strategies for Assessing and Addressing Confounding

Confounding is a critical issue in epidemiological studies, often leading to misleading conclusions about associations between exposures and outcomes. It occurs when the relationship between the exposure and the outcome is mixed with the effects of other factors that influence the outcome. Given that, addressing confounding is of high importance for drawing accurate inferences in research.
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
Blinding01:11

Blinding

Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Scapular belt for the treatment of comminuted fractures of scapula].

Zhongguo gu shang = China journal of orthopaedics and traumatology·2010
Same author

Manipulation of ordered nanostructures of protonated polyoxometalate through covalently bonded modification.

Chemistry (Weinheim an der Bergstrasse, Germany)·2010
Same author

Developments in nonsteroidal antiandrogens targeting the androgen receptor.

ChemMedChem·2010
Same author

Dynamic presentation of immobilized ligands regulated through biomolecular recognition.

Journal of the American Chemical Society·2010
Same author

[Research on crop-weed discrimination using a field imaging spectrometer].

Guang pu xue yu guang pu fen xi = Guang pu·2010
Same author

A palladium/copper bimetallic catalytic system: dramatic improvement for Suzuki-Miyaura-type direct C-H arylation of azoles with arylboronic acids.

Chemistry (Weinheim an der Bergstrasse, Germany)·2010

Related Experiment Video

Updated: Jun 24, 2026

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

Leveraging external controls in clinical trials: estimands, estimation, assumptions.

Bo Liu1, Fan Li1, Rury R Holman2

  • 1Department of Statistical Science, Duke University, Durham, NC, USA.

Journal of Biopharmaceutical Statistics
|June 23, 2026
PubMed
Summary

Augmenting randomized controlled trials with external data improves treatment effect estimation. New methods combine concurrent and external controls without strict assumptions, enhancing causal inference accuracy.

Keywords:
Causal inferenceefficient influence functionestimandexternal controlpropensity scoreweighting

Related Experiment Videos

Last Updated: Jun 24, 2026

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

Area of Science:

  • Biostatistics
  • Clinical Trials
  • Epidemiology

Background:

  • Randomized controlled trials (RCTs) are often augmented with external controls from observational data to assess intervention effects.
  • Traditional methods for treatment effect estimation rely on ambiguous causal estimands and strong assumptions like mean exchangeability.
  • Implicit biases in causal inference arise from various sources, complicating accurate treatment effect evaluation.

Purpose of the Study:

  • To introduce a transparent framework for defining causal estimands using double-indexed potential outcomes notation.
  • To develop a novel statistical method for estimating treatment effects by integrating concurrent and external control data.
  • To address limitations of existing methods by removing the need for mean exchangeability assumptions.

Main Methods:

  • Developed a double-indexed notation for potential outcomes to clearly define causal estimands and identify sources of bias.
  • Derived a consistent and locally efficient estimator for weighted average treatment effect (WATE) estimands.
  • Proposed a Frisch-Waugh-Lovell style partial regression method to estimate systematic outcome differences between concurrent and external units.

Main Results:

  • Demonstrated the critical role of the concurrent control arm in validating assumptions and enabling unbiased causal estimation.
  • The proposed estimator successfully combines concurrent and external data without requiring mean exchangeability.
  • Simulations and application to cardiovascular trials showed the proposed methods outperform existing approaches.

Conclusions:

  • The novel approach offers a more robust and transparent method for causal inference in clinical trials by integrating diverse data sources.
  • This framework enhances the reliability of treatment effect estimation when external data is used to augment RCTs.
  • The proposed estimator provides a valuable tool for biostatisticians and clinical researchers seeking accurate causal effect evaluation.